CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Report
- Dong Wan Kim
- , Sang We Kim
- , D. Ross Camidge
- , Catherine A. Shu
- , Kristen A. Marrone
- , Xiuning Le
- , Collin M. Blakely
- , Keunchil Park
- , Gee Chen Chang
- , Sandip Pravin Patel
- , Gozde Kar
- , Zachary A. Cooper
- , Ramin Samadani
- , Michael Pluta
- , Rakesh Kumar
- , Suresh Ramalingam
Research output: Contribution to journal › Article › peer-review